Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

prostate cancer

  • Open Access
    68Ga-PSMA PET/CT and Prostate Cancer Diagnosis: Which SUVmax Value?
    PIETRO PEPE, LUDOVICA PEPE, MARIA TAMBURO, GIULIA MARLETTA, FRANCESCO SAVOCA, MICHELE PENNISI and FILIPPO FRAGGETTA
    In Vivo May 2023, 37 (3) 1318-1322; DOI: https://doi.org/10.21873/invivo.13211
  • Open Access
    Prostate-specific Antigen Levels Following Brachytherapy Impact Late Biochemical Recurrence in Japanese Patients With Localized Prostate Cancer
    YOSHITERU UENO, TOMOHARU FUKUMORI, YOSHITO KUSUHARA, TOMOYA FUKAWA, MEGUMI TSUDA, KEI DAIZUMOTO, YUTARO SASAKI, RYOTARO TOMIDA, YASUYO YAMAMOTO, KUNIHISA YAMAGUCHI, CHISATO TONOISO, AKIKO KUBO, TAKASHI KAWANAKA, SHUNSUKE FURUTANI, HITOSHI IKUSHIMA, MASAYUKI TAKAHASHI and HIRO-OMI KANAYAMA
    In Vivo March 2023, 37 (2) 738-746; DOI: https://doi.org/10.21873/invivo.13136
  • Open Access
    Moderately Hypofractionated Helical Tomotherapy for Prostate Cancer: Ten-year Experience of a Mono-institutional Series of 415 Patients
    SALVATORE COZZI, MARIA PAOLA RUGGIERI, EMANUELE ALÌ, SEBASTIANO FINOCCHI GHERSI, FEDERICA VIGO, MATTEO AUGUGLIARO, LUCIA GIACCHERINI, FEDERICO IORI, MASOUMEH NAJAFI, LILIA BARDOSCIA, ANDREA BOTTI, VALERIA TROJANI, PATRIZIA CIAMMELLA and CINZIA IOTTI
    In Vivo March 2023, 37 (2) 777-785; DOI: https://doi.org/10.21873/invivo.13141
  • Open Access
    Assessment of Prostate Volume and Prostate-specific Antigen Density With the Segmentation Method on Magnetic Resonance Imaging
    YEN-TING LIN, SIU-WAN HUNG, KUN-YUAN CHIU, JYH-WEN CHAI and JIN-CHING LIN
    In Vivo March 2023, 37 (2) 786-793; DOI: https://doi.org/10.21873/invivo.13142
  • Open Access
    Distinct Expression of Surface and Genetic Biomarkers in Prostate Cancer Cell Lines
    CHEN-YING SU, GWO-CHE HUANG, I-CHENG CHEN, PEI-YU CHEN, YU-JEN CHEN and HSU-WEI FANG
    In Vivo January 2023, 37 (1) 242-246; DOI: https://doi.org/10.21873/invivo.13073
  • Open Access
    Chemosensitizing Effect and Efficacy of Wilforlide A in Combination With Docetaxel in Drug-resistant Prostate Cancer
    ZHIJUN WANG, STEVEN YEUNG, SHANCHAO YANG, YING HUANG and MOSES SING SUM CHOW
    In Vivo September 2022, 36 (5) 2020-2031; DOI: https://doi.org/10.21873/invivo.12928
  • Open Access
    Quantitative Analysis of Diffusion Weighted Imaging May Improve Risk Stratification of Prostatic Transition Zone Lesions
    HANNES ENGEL, BENEDICT OERTHER, MARCO REISERT, ELIAS KELLNER, AUGUST SIGLE, CHRISTIAN GRATZKE, PETER BRONSERT, TOBIAS KRAUSS, FABIAN BAMBERG and MATTHIAS BENNDORF
    In Vivo September 2022, 36 (5) 2323-2331; DOI: https://doi.org/10.21873/invivo.12963
  • Open Access
    Non-invasively Imageable Tibia-tumor-fragment Implantation Experimental-bone-metastasis Mouse Model of GFP-expressing Prostate Cancer
    YUSUKE AOKI, NORIYUKI MASAKI, YASUNORI TOME, YUTARO KUBOTA, YASUYO AOKI, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN
    In Vivo July 2022, 36 (4) 1647-1650; DOI: https://doi.org/10.21873/invivo.12876
  • Open Access
    Cranial Radiotherapy for Prostate Cancer Patients With Brain Metastases Inaccessible to Stereotactic Radiotherapy
    CHRISTINA SCHRÖDER, PAUL WINDISCH, JAMIE LÜTSCHER, DANIEL R. ZWAHLEN and ROBERT FÖRSTER
    In Vivo July 2022, 36 (4) 1841-1846; DOI: https://doi.org/10.21873/invivo.12901
  • Open Access
    Acute and Late Rectal Toxicity Following Hypofractionated Radiotherapy in Patients With Prostate Cancer: Results of a Prospective Study
    GEORGIOS KOUNADIS, NIKOLAOS SYRIGOS, ANDROMACHI KOUGIOUMTZOPOULOU, GEORGIOS BAMIAS, ILIAS KOTTEAS, GEORGIOS PAPATHEODORIDIS and DIMITRA GRAPSA
    In Vivo July 2022, 36 (4) 1875-1880; DOI: https://doi.org/10.21873/invivo.12906

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
In Vivo

© 2023 In Vivo

Powered by HighWire